Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS & IGF Society Increasing somavaratan dose to the 3.5mg/kg twice-monthly now used in Phase 3 safely improved IGF-I SDS and...
The Ohio State University Wexner Medical Center Implements Kyruus ProviderMatch to Optimize Patient Access by Kyruus, on Oct 26, 2016 9:05:48 AM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions, announced today that The Ohio State University...
CRISPR Therapeutics Announces Pricing of Initial Public Offering BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) — CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing...
TigerText Introduces TigerFlow, The Next Evolution In Clinical Communications Oct 20, 2016 TigerText Advancing well beyond secure messaging, TigerFlow delivers a sweeping, first-of-its-kind, workflow-centric clinical communication solution that brings together an...
True North Therapeutics Receives FDA Orphan Drug Designation for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) South San Francisco, CA, October 13, 2016 — True North Therapeutics, a clinical stage biotechnology...
Recent Comments